Dr. Aaron Y. Lee, MD
Retina Specialist (Retina Specialist (Ophthalmology) Physician)
4901 Forest Park Ave, Dept Ophthalmology, 6th Fl
Saint Louis, MO 63108
- Medicare participating
At a glance
- Years since graduation
- 17
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 59
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Retina Specialist (Ophthalmology) Physician primary
MO license 2025032857
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Barnes Jewish Hospital Saint Louis, MO
Medical groups
- Washington University (3,029 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 59
- Services billed
- 831
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Imaging of retina | 50 | 37 |
| Established patient office or other outpatient visit, 20-29 minutes | 21 | 20 |
| Injection of drug into eye | 16 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 5 companies reported 14 payments worth $11,386 in total to this clinician.
| Alcon Research LLC | $5,000 |
|---|---|
| Janssen Pharmaceuticals, Inc | $2,550 |
| Apellis Pharmaceuticals, Inc. | $2,365 |
| Carl Zeiss Meditec, Inc. | $1,200 |
| Topcon Healthcare, Inc. | $271 |
| Consulting Fee | $6,115 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $5,000 |
| Food and Beverage | $151 |
| Travel and Lodging | $120 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Alcon Research LLC Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,000 |
| Apellis Pharmaceuticals, Inc. Jun 20, 2025 | Consulting Fee Syfovre · Ophthalmology | $2,365 |
| Carl Zeiss Meditec, Inc. Jun 2, 2025 | Consulting FeeCompany’s descriptionZeiss has contractual agreements with Healthcare Professionals and Organizations to consult, validate, or participate in research activities. | $1,200 |
| Janssen Pharmaceuticals, Inc Jan 28, 2025 | Consulting Fee | $850 |
| Janssen Pharmaceuticals, Inc Jan 28, 2025 | Consulting Fee | $425 |
| Janssen Pharmaceuticals, Inc Jan 28, 2025 | Consulting Fee | $425 |
| Janssen Pharmaceuticals, Inc Jun 27, 2025 | Consulting Fee | $425 |
| Janssen Pharmaceuticals, Inc Jan 28, 2025 | Consulting Fee | $425 |
| Topcon Healthcare, Inc. Jul 22, 2025 | Travel and Lodging travel to San Diego, CA Company’s descriptionTravel and Lodging | $120 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $36,693 in research payments for these studies, mostly to the institutions running them.
- Cross Sectional Correlation Of Optical Coherence Tomography Images Acquired From Multiple Devices
Genentech, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.